Unilever Consumer Care Limited announcements
322 Dhaka Stock Exchange announcements for Unilever Consumer Care Limited (UNILEVERCL) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2014 (12).
- Q3 earnings
(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2014 (July'14 to Sep'14), the Company has reported net profit after tax of Tk. 157.56 million with EPS of Tk. 13.08 as against Tk. 75.44 million and Tk. 6.26 respectively for the same period of the previous year. Whereas net profit after tax was Tk. 568.09 million with EPS of Tk. 47.16 for the period of nine months (Jan'14 to Sep'14) ended on 30.09.2014 as against Tk. 421.91 million and Tk. 35.02 respectively for the same period of the previous year.
Posted under the former code GLAXOSMITH. - H/F earnings
As per un-audited half yearly accounts as on 30.06.2014 (Jan'14 to June'14), the Company has reported profit after tax of Tk. 410.53 million with EPS of Tk. 34.08 as against Tk. 346.47 million and Tk. 28.76 respectively for the same period of the previous year. Whereas profit after tax was Tk. 181.01 million with EPS of Tk. 15.03 for the period of 3 months (Apr'14 to June'14) ended on 30.06.2014 as against Tk. 149.93 million and Tk. 12.45 respectively for the same period of the previous year.
Posted under the former code GLAXOSMITH. - DSE query
In response to a DSE query dated April 23, 2014 regarding clarification of newspaper reporting relating to "inter-conditional business transaction between Novartis and GlaxoSmithKline" published in "The Daily Prothom Alo" dated April 23, 2014, the Company has informed that "the announcement on inter-conditional business transaction between GlaxoSmithKline Plc and Novartis has been taken by the holding company and we have no knowledge on the transaction and has no clear view on the impact of our business in Bangladesh till the completion of transaction in 2015".
Posted under the former code GLAXOSMITH. - In response to a DSE query dated April 23, 2014 regarding clarification of newspaper reporting relating to "inter-condit
In response to a DSE query dated April 23, 2014 regarding clarification of newspaper reporting relating to "inter-conditional business transaction between Novartis and GlaxoSmithKline" published in "The Daily Prothom Alo" dated April 23, 2014, the Company has informed that "the announcement on inter-conditional business transaction between GlaxoSmithKline Plc and Novartis has been taken by the holding company and we have no knowledge on the transaction and has no clear view on the impact of our business in Bangladesh till the completion of transaction in 2015".
Posted under the former code GLAXOSMITH. - (Q1): As per un-audited quarterly accounts for the 1st quarter ended on 31st March 2014 (Jan'14 to March'14), the Compan
(Q1): As per un-audited quarterly accounts for the 1st quarter ended on 31st March 2014 (Jan'14 to March'14), the Company has reported profit after tax of Tk. 229.52 million with EPS of Tk. 19.05 as against Tk. 196.53 million and Tk. 16.31 respectively for the same period of the previous year.
Posted under the former code GLAXOSMITH. - trade resume
Normal trading of the shares of the Company will resume on 13.03.2014 after record date.<br>
Posted under the former code GLAXOSMITH. - Normal trading of the shares of the Company will resume on 13.03.2014 after record date.
Normal trading of the shares of the Company will resume on 13.03.2014 after record date.
Posted under the former code GLAXOSMITH. - Trading of the shares of the Company will remain suspended on record date i.e., 12.03.2014.
Trading of the shares of the Company will remain suspended on record date i.e., 12.03.2014.
Posted under the former code GLAXOSMITH. - Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 09.03.2014 to 11.03.2014. Trading of the shares of the Company will remain suspended on record date i.e., 12.03.2014.
Posted under the former code GLAXOSMITH. - The Board of Directors has recommended 300% cash dividend for the year ended on December 31, 2013. Date of AGM: 24.04.20
The Board of Directors has recommended 300% cash dividend for the year ended on December 31, 2013. Date of AGM: 24.04.2014, Time: 11:00 AM, Venue: Hotel Agrabad, Chittagong. Record date: 12.03.2014. The Company has also reported EPS of Tk. 45.35, NAV per share of Tk. 153.67 and NOCFPS of Tk. 82.22 for the year ended on December 31, 2013.
Posted under the former code GLAXOSMITH. - There will be no price limit on the trading of the shares of the Company today (23.02.2014) following its corporate decl
There will be no price limit on the trading of the shares of the Company today (23.02.2014) following its corporate declaration.
Posted under the former code GLAXOSMITH. - As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will
As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on February 20, 2014 at 4:30 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2013.
Posted under the former code GLAXOSMITH.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.